183 related articles for article (PubMed ID: 34398900)
1. The role of multiple metabolic genes in predicting the overall survival of colorectal cancer: A study based on TCGA and GEO databases.
Shi W; Li X; Su X; Wen H; Chen T; Wu H; Liu M
PLoS One; 2021; 16(8):e0251323. PubMed ID: 34398900
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis.
Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F
Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544
[TBL] [Abstract][Full Text] [Related]
3. Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer.
Lin D; Fan W; Zhang R; Zhao E; Li P; Zhou W; Peng J; Li L
J Transl Med; 2021 Jun; 19(1):279. PubMed ID: 34193202
[TBL] [Abstract][Full Text] [Related]
4. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
5. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
6. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
7. A novel prognostic risk score model based on immune-related genes in patients with stage IV colorectal cancer.
Xu K; He J; Zhang J; Liu T; Yang F; Ren T
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33034614
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of 3-CpG methylation prognostic signature based on different survival indicators for colorectal cancer.
Huang H; Zhang L; Fu J; Tian T; Liu X; Liu Y; Sun H; Li D; Zhu L; Xu J; Zheng T; Jia C; Zhao Y
Mol Carcinog; 2021 Jun; 60(6):403-412. PubMed ID: 33826760
[TBL] [Abstract][Full Text] [Related]
9. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
Gao X; Yang J
DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
[TBL] [Abstract][Full Text] [Related]
10. A five-immune-related genes-based prognostic signature for colorectal cancer.
Zhu L; Wang H; Wang Z
Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
[TBL] [Abstract][Full Text] [Related]
11. Identification of a five-gene signature with prognostic value in colorectal cancer.
Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
[TBL] [Abstract][Full Text] [Related]
12. Upregulated NLGN1 predicts poor survival in colorectal cancer.
Yu Q; Wang X; Yang Y; Chi P; Huang J; Qiu S; Zheng X; Chen X
BMC Cancer; 2021 Aug; 21(1):884. PubMed ID: 34340665
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Novel Ferroptosis-Related Gene Prediction Model for Clinical Prognosis and Immunotherapy of Colorectal Cancer.
Yang YB; Zhou JX; Qiu SH; He JS; Pan JH; Pan YL
Dis Markers; 2021; 2021():4846683. PubMed ID: 34868393
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of metabolism-associated gene signatures in colorectal cancer.
Miao Y; Li Q; Wang J; Quan W; Li C; Yang Y; Mi D
PeerJ; 2020; 8():e9847. PubMed ID: 32953273
[TBL] [Abstract][Full Text] [Related]
15. Construction of a Colorectal Cancer Prognostic Risk Model and Screening of Prognostic Risk Genes Using Machine-Learning Algorithms.
Du X; Qi H; Ji W; Li P; Hua R; Hu W; Qi F
Comput Math Methods Med; 2022; 2022():9408839. PubMed ID: 36267311
[TBL] [Abstract][Full Text] [Related]
16. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients.
Du S; Zeng F; Sun H; Liu Y; Han P; Zhang B; Xue W; Deng G; Yin M; Cui B
Bioengineered; 2022 Feb; 13(2):2498-2512. PubMed ID: 35067161
[TBL] [Abstract][Full Text] [Related]
18. Exploring prognostic potential of long noncoding RNAs in colorectal cancer based on a competing endogenous RNA network.
Yang ZD; Kang H
World J Gastroenterol; 2020 Mar; 26(12):1298-1316. PubMed ID: 32256018
[TBL] [Abstract][Full Text] [Related]
19. A prognostic fibroblast-related risk signature in colorectal cancer.
Xu H; Pan Y
Aging (Albany NY); 2021 Nov; 13(21):24251-24270. PubMed ID: 34735373
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
